The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia

被引:7
作者
Horvitz-Lennon, Marcela [1 ]
Predmore, Zachary [1 ,3 ]
Orr, Patrick [1 ,5 ]
Hanson, Mark [2 ,4 ]
Hillestad, Richard [2 ]
Durkin, Mike [6 ]
El Khoury, Antoine C. [6 ]
Mattke, Soeren [1 ,4 ]
机构
[1] RAND Corp, 20 Pk Plaza,Suite 920, Boston, MA 02116 USA
[2] RAND Corp, Santa Monica, CA USA
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Univ Southern Calif, Los Angeles, CA 90007 USA
[5] Informat Mapping, Boston, MA USA
[6] Janssen Sci Affairs LLC, Titusville, NJ USA
关键词
Schizophrenia; Treatment adherence; Early detection; Simulation; QUALITY-OF-LIFE; UNTREATED PSYCHOSIS; 1ST-EPISODE SCHIZOPHRENIA; EARLY INTERVENTION; NEGATIVE SYMPTOMS; MENTAL-ILLNESS; UNITED-STATES; DURATION; DISORDERS; PEOPLE;
D O I
10.1007/s10488-019-00990-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The impact of initiatives aimed at reducing time in untreated psychosis during early-stage schizophrenia will be unknown for many years. Thus, we simulate the effect of earlier treatment entry and better antipsychotic drug adherence on schizophrenia-related hospitalizations, receipt of disability benefits, competitive employment, and independent/family living over a ten-year horizon. We predict that earlier treatment entry reduces hospitalizations by 12.6-14.4% and benefit receipt by 7.0-8.5%, while increasing independent/family living by 41.5-46% and employment by 42-58%. We predict larger gains if a pro-adherence intervention is also used. Our findings suggest substantial benefits of timely and consistent early schizophrenia care.
引用
收藏
页码:357 / 365
页数:9
相关论文
共 53 条
[31]  
Melle I, 2012, EARLY INTERV PSYCHIA, V6, P5
[32]   Is Early Intervention in Psychosis Cost-Effective Over the Long Term? [J].
Mihalopoulos, Cathrine ;
Harris, Meredith ;
Henry, Lisa ;
Harrigan, Susy ;
McGorry, Patrick .
SCHIZOPHRENIA BULLETIN, 2009, 35 (05) :909-918
[33]  
National Institute of Mental Health, REC IN SCHIZ EP RAIS
[34]   The relationship of symptoms and level of functioning in schizophrenia to general wellbeing and the Quality of Life Scale [J].
Norman, RMG ;
Malla, AK ;
McLean, T ;
Voruganti, LPN ;
Cortese, L ;
McIntosh, E ;
Cheng, S ;
Rickwood, A .
ACTA PSYCHIATRICA SCANDINAVICA, 2000, 102 (04) :303-309
[35]  
Olfson M, 2011, PSYCHIAT SERV, V62, P1138, DOI 10.1176/ps.62.10.pss6210_1138
[36]   Can We Reduce the Duration of Untreated Psychosis? A Systematic Review and Meta-Analysis of Controlled Interventional Studies [J].
Oliver, Dominic ;
Davies, Cathy ;
Crossland, Georgia ;
Lim, Steffiany ;
Gifford, George ;
McGuire, Philip ;
Fusar-Poli, Paolo .
SCHIZOPHRENIA BULLETIN, 2018, 44 (06) :1362-1372
[37]   Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis [J].
Penttila, Matti ;
Jaaskelainen, Erika ;
Hirvonen, Noora ;
Isohanni, Matti ;
Miettunen, Jouko .
BRITISH JOURNAL OF PSYCHIATRY, 2014, 205 (02) :88-94
[38]   Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: A critical review and meta-analysis [J].
Perkins, DO ;
Gu, HB ;
Boteva, K ;
Lieberman, JA .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (10) :1785-1804
[39]   Prescription Practices in the Treatment of First-Episode Schizophrenia Spectrum Disorders: Data From the National RAISE-ETP Study [J].
Robinson, Delbert G. ;
Schooler, Nina R. ;
John, Majnu ;
Correll, Christoph U. ;
Marcy, Patricia ;
Addington, Jean ;
Brunette, Mary F. ;
Estroff, Sue E. ;
Mueser, Kim T. ;
Penn, David ;
Robinson, James ;
Rosenheck, Robert A. ;
Severe, Joanne ;
Goldstein, Amy ;
Azrin, Susan ;
Heinssen, Robert ;
Kane, John M. .
AMERICAN JOURNAL OF PSYCHIATRY, 2015, 172 (03) :237-248
[40]   Barriers to employment for people with schizophrenia [J].
Rosenheck, R ;
Leslie, D ;
Keefe, R ;
McEvoy, J ;
Swartz, M ;
Perkins, D ;
Stroup, S ;
Hsiao, JK ;
Lieberman, J .
AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (03) :411-417